39499391|t|Amyloid beta-induced signalling in leptomeningeal cells and its impact on astrocyte response.
39499391|a|The pathological signature of Alzheimer's disease (AD) includes the accumulation of toxic protein aggregates, mainly consisting of amyloid beta (Abeta). Recent strides in fundamental research underscore the pivotal role of waste clearance mechanisms in the brain suggesting it may be an early indication of early onset AD. This study delves into the involvement of leptomeningeal cells (LMCs), crucial components forming integral barriers within the clearance system, in the context of AD. We examined the inflammatory cytokine responses of LMCs in the presence of Abeta, alongside assessments of LMC growth response, viability, oxidative stress, and changes in vimentin expression. The LMCs showed no changes in growth, viability, oxidative stress, or vimentin expression in the presence of Abeta, indicating that LMCs are less susceptible to Abeta damage compared to other CNS cells. However, LMCs exhibited a unique pro-inflammatory response to Abeta when compared to an LPS inflammatory control, showing an mRNA expression of pro-inflammatory cytokines such IL-6, IL-10 and IL-33 but no changes in IL-1alpha and IL-1beta. Furthermore, LMCs influenced the astrocyte response to Abeta, as conditioned media from Abeta-treated LMCs was observed to downregulate somatic S100beta in astrocytes. We also investigated whether the JAK/STAT3 pathway was involved in the Abeta response of the LMCs, as this pathway has been shown to be activated in astrocytes and neurons in the presence of Abeta. JAK/STAT3 activation was assessed through phosphorylated STAT3, revealing that JAK/STAT3 was not active in the cells when in the presence of Abeta. However, when JAK1 and JAK2 were inhibited, cytokine protein levels of IL7, IL10, IL15 and IL33 levels, which had shown alteration when LMCs were treated with Abeta, returned to base levels. This indicates that although JAK1/STAT3 and JAK2/STAT3 are not the direct pathway for Abeta response in LMCs, JAK1 and JAK2 may still play a role in regulating cytokine levels, potentially through indirect means or crosstalk. Overall, our findings reveal that LMCs are resilient to Abeta toxicity and suggest that JAK1/STAT3 and JAK2/STAT3 does not play a central role in the inflammatory response, providing new insights into the cellular mechanisms underlying AD.
39499391	0	12	Amyloid beta	Gene	351
39499391	124	143	Alzheimer's disease	Disease	MESH:D000544
39499391	145	147	AD	Disease	MESH:D000544
39499391	225	237	amyloid beta	Gene	351
39499391	239	244	Abeta	Gene	351
39499391	413	415	AD	Disease	MESH:D000544
39499391	580	582	AD	Disease	MESH:D000544
39499391	600	612	inflammatory	Disease	MESH:D007249
39499391	659	664	Abeta	Gene	351
39499391	756	764	vimentin	Gene	7431
39499391	847	855	vimentin	Gene	7431
39499391	886	891	Abeta	Gene	351
39499391	938	943	Abeta	Gene	351
39499391	1017	1029	inflammatory	Disease	MESH:D007249
39499391	1042	1047	Abeta	Gene	351
39499391	1068	1071	LPS	Chemical	MESH:D008070
39499391	1072	1084	inflammatory	Disease	MESH:D007249
39499391	1128	1140	inflammatory	Disease	MESH:D007249
39499391	1156	1160	IL-6	Gene	3569
39499391	1162	1167	IL-10	Gene	3586
39499391	1172	1177	IL-33	Gene	90865
39499391	1196	1205	IL-1alpha	Gene	3552
39499391	1210	1218	IL-1beta	Gene	3553
39499391	1275	1280	Abeta	Gene	351
39499391	1308	1313	Abeta	Gene	351
39499391	1364	1372	S100beta	Gene	6285
39499391	1425	1430	STAT3	Gene	6774
39499391	1459	1464	Abeta	Gene	351
39499391	1579	1584	Abeta	Gene	351
39499391	1590	1595	STAT3	Gene	6774
39499391	1643	1648	STAT3	Gene	6774
39499391	1669	1674	STAT3	Gene	6774
39499391	1727	1732	Abeta	Gene	351
39499391	1748	1752	JAK1	Gene	3716
39499391	1757	1761	JAK2	Gene	3717
39499391	1805	1808	IL7	Gene	3574
39499391	1810	1814	IL10	Gene	3586
39499391	1816	1820	IL15	Gene	3600
39499391	1825	1829	IL33	Gene	90865
39499391	1893	1898	Abeta	Gene	351
39499391	1954	1958	JAK1	Gene	3716
39499391	1959	1964	STAT3	Gene	6774
39499391	1969	1973	JAK2	Gene	3717
39499391	1974	1979	STAT3	Gene	6774
39499391	2011	2016	Abeta	Gene	351
39499391	2035	2039	JAK1	Gene	3716
39499391	2044	2048	JAK2	Gene	3717
39499391	2207	2212	Abeta	Gene	351
39499391	2213	2221	toxicity	Disease	MESH:D064420
39499391	2239	2243	JAK1	Gene	3716
39499391	2244	2249	STAT3	Gene	6774
39499391	2254	2258	JAK2	Gene	3717
39499391	2259	2264	STAT3	Gene	6774
39499391	2301	2313	inflammatory	Disease	MESH:D007249
39499391	2387	2389	AD	Disease	MESH:D000544
39499391	Association	351	3586
39499391	Association	MESH:D000544	351
39499391	Positive_Correlation	3717	90865
39499391	Association	MESH:D007249	351
39499391	Association	351	3717
39499391	Positive_Correlation	MESH:D007249	90865
39499391	Positive_Correlation	3586	3717
39499391	Association	3716	90865
39499391	Association	3586	3716
39499391	Association	351	90865
39499391	Positive_Correlation	MESH:D007249	3569
39499391	Positive_Correlation	3600	3717
39499391	Association	351	3569
39499391	Positive_Correlation	MESH:D008070	MESH:D007249
39499391	Positive_Correlation	3600	3716
39499391	Positive_Correlation	3574	3716
39499391	Positive_Correlation	3574	3717
39499391	Association	MESH:D007249	3586
39499391	Negative_Correlation	351	6285

